209984-17-8

Basic information

• Product Name: 3-(S)-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)amino-1-methyl-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
• CAS NO: 209984-17-8
• Molecular Weight: 415.44
• Mol File: 209984-17-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(S)-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)amino-1-methyl-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(S)-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)amino-1-methyl-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one(209984-17-8)
• EPA Substance Registry System: 3-(S)-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)amino-1-methyl-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one(209984-17-8)

Safety Data

• Hazardous Substances Data: 209984-17-8(Hazardous Substances Data)

Upstream product

• 103825-24-7 3-amino-1-methyl-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one 
• 208124-34-9 N-(3,5-Difluorophenylacetyl)-L-alanine 

Relevant articles and documents

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.